BVS FY 2019 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$581M

FY 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$340M+6.6% YoY

Gross Profit

$249M73.3% margin

Operating Income

$31M9.2% margin

Net Income

$7M2.0% margin

EPS (Diluted)

$0.12

Cash Flow

Operating Cash Flow

$41M

Free Cash Flow

$32M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$472M

Total Liabilities

$327M

Stockholders' Equity

$143M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$340M	$319M	+6.6%
Gross Profit	$249M	$235M	+6.0%
Operating Income	$31M	$26M	+22.3%
Net Income	$7M	-$12M	+156.1%